1,964 reports of this reaction
3.3% of all NYSTATIN reports
#1 most reported adverse reaction
NAUSEA is the #1 most commonly reported adverse reaction for NYSTATIN, manufactured by Padagis US LLC. There are 1,964 FDA adverse event reports linking NYSTATIN to NAUSEA. This represents approximately 3.3% of all 59,130 adverse event reports for this drug.
NYSTATIN has an overall safety score of 82 out of 100. Patients taking NYSTATIN who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among NYSTATIN users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for NYSTATIN:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,964 FDA reports for NYSTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.3% of all adverse event reports for NYSTATIN, making it one of the most commonly reported side effect.
If you experience nausea while taking NYSTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.